Unjoni Ewropea - Malti - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influwenza, bniedem - vaċċini kontra l-influwenza, influwenza, ħaj attenwat - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. l-użu ta 'fluenz tetra għandu jkun ibbażat fuq rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

seqirus gmbh - virus tal-influwenza antiġeni tal-wiċċ (haemagglutinin u neuraminidase), inattivati, tar-razez li ġejjin:/california/7/2009 (h1n1)pdm09 - like strain(a/brisbane/10/2010, tat-tip selvaġġ)a/svizzera/9715293/2013 (h3n2) like strain(a/nofsinhar l-awstralja/55/2014, tat-tip selvaġġ)b/kulħadd jinstemgħu/3073/2013–like strain(b/utah/9/2014, tat-tip selvaġġ) - influenza, human; immunization - vaċċini - profilassi tal-influwenza għall-adulti, speċjalment f'dawk li għandhom riskju ogħla ta 'kumplikazzjonijiet assoċjati. optaflu m'għandu jintuża skont il-gwida uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaċċini - active immunisation against h5 subtype of influenza a virus.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

medimmune llc - reassortant-virus tal-influwenza (ħaj attenwat) tar-razez li ġejjin:/california/7/2009 (h1n1)pdm09 bħal strejn, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain - influenza, human; immunization - vaċċini - profilassi ta 'l-influwenza f'individwi ta' 24 xahar sa inqas minn 18-il sena. l-użu ta fluenz għandu jkun ibbażat fuq rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - influwenza, bniedem - l-influwenza, mhux attivat, maqsuma virus jew antiġen tal-wiċċ - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra għandu jintuża skond ir-rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - antigens tal-wiċċ tal-virus tal-influwenza (emagglutinin u neuraminidase) ta 'razza a / vjet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaċċini - immunizzazzjoni attiva kontra s-sottotip h5n1 tal-virus influwenza a.. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

sanofi pasteur europe - virus tal-influwenza (inattivat, maqsuma) tar-razez li ġejjin:/california/7/2009 (h1n1)pdm09 - like strain (a/california/7/2009, nymc x-179a)a/hong kong/4801/2014 (h3n2) like strain (a/hong kong/4801/2014, nymc x-263b)b/brisbane/60/2008 - like strain (b/brisbane/60/2008, tat-tip selvaġġ) - influenza, human; immunization - vaċċini - profilassi ta 'l-influwenza f'individwi ta' 60 sena jew aktar, speċjalment f'dawk li għandhom riskju akbar ta 'kumplikazzjonijiet assoċjati. l-użu ta ' intanza għandu jkun ibbażat fuq rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) / a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238) / b/phuket/3073/2013-like strain (b/phuket/3073/2013, bvr-1b) / influenza virus b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - influwenza, bniedem - vaċċini - profilassi tal-influwenza fl-anzjani (65 sena u aktar). fluad tetra għandu jintuża skond ir-rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vaċċini - profilassi tal-influwenza kkawżata mill-virus a (h1n1) v 2009. celvapan ma għandu jintuża skont il-gwida uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zoetis belgium sa - klieb distemper virus, razza cdv bio 11/a, klieb adenovirus tat-tip 2, razza cav-2 bio 13, klieb parvovirus tip 2b, razza cpv-2b bio 12/b, klieb parainfluenza tat-tip 2 virus, razza cpiv-2 bio 15 (kollha ħaj attenwat), leptospira interrogans serogrupp ma ' serotip bratislava, razza mslb 1088, l. interrogans serogrupp icterohaemorrhagiae serotip icterohaemorrhagiae, razza mslb 1089, l. interrogans serogrupp canicola serotip canicola, razza mslb 1090, l. kirschneri serogrupp grippotyphosa serotip grippotyphosa, razza mslb 1091... - ħajjin-klieb distemper virus + ħajjin-klieb adenovirus + ħajjin-klieb parainfluenza virus + ħajjin-klieb parvovirus + inattivat leptospira, immunoloġiċi għall-canidae - klieb - tilqim attiv ta 'klieb ta' età ta '6 ġimgħat:biex tipprevjeni l-mortalità u sinjali kliniċi ikkawżati mill-klieb distemper virus,biex jimpedixxi l-mortalità u sinjali kliniċi ikkawżati mill-klieb adenovirus tat-tip 1,li jipprevjenu l-sinjali kliniċi u l-eskrezzjoni virali kkawżata mill-klieb adenovirus tat-tip 2,għall-prevenzjoni ta' sinjali kliniċi, lewkopenja u l-eskrezzjoni virali kkawżata mill-klieb parvovirus,għall-prevenzjoni tal-sinjali kliniċi (nażali u okulari kwittanza) u l-eskrezzjoni virali kkawżata mill-klieb parainfluenza tal-virus,li jipprevjenu l-sinjali kliniċi, l-infezzjoni u l-eskrezzjoni fl-awrina kkawżati minn l. interrogans serogrupp ma ' serotip bratislava,għall-prevenzjoni tal-sinjali kliniċi u l-eskrezzjoni fl-awrina u tnaqqas infezzjoni kkawżata minn l. interrogans serogrupp canicola serovar canicola u l. interrogans serogrupp icterohaemorrhagiae serotip icterohaemorrhagiae u għall-prevenzjoni ta ' sinjali kliniċi u tnaqqas infezzjoni u tneħħija fl-awrina kkawżati minn l. interrogans serogrupp grippotyphosa serovar grippotyphosa.